Chester County News and Community Website
WILMINGTON, DE — AstraZeneca has secured U.S. regulatory approval for IMFINZI (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) therapy for adults with previously untreated high-risk non-muscle-invasive bladder cancer, expanding the …
AstraZeneca Wins FDA Approval for IMFINZI in Early Bladder Cancer Read More
WILMINGTON, DE — Qnity Electronics (NYSE: Q) has received ASE Technology Holding’s 2025 Best Supplier Award, a recognition that highlights the company’s position in the semiconductor packaging supply chain as …
Qnity Wins ASE Supplier Award Amid Growing AI Chip Demand Read More
WILMINGTON, DE — Phreesia (NYSE: PHR) reported a return to profitability and double-digit revenue growth in its fiscal first quarter, as the healthcare technology company integrates its AccessOne acquisition and …
Phreesia Posts Profit as AccessOne Expansion Fuels Growth Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) is scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, providing investors with an opportunity to hear updates …
Incyte to Present Strategy Update at Goldman Sachs Healthcare Conference Read More
WILMINGTON, DE — Warehouse management software provider PULPO WMS has launched a client-facing portal aimed at helping third-party logistics providers offer greater operational visibility to customers as technology capabilities become …
PULPO Adds Client Portal as 3PLs Face Technology Pressure Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo have secured U.S. approval for DATROWAY as a first-line treatment for certain patients with metastatic triple-negative breast cancer, expanding treatment options in a …
AstraZeneca, Daiichi Sankyo Win FDA Approval for DATROWAY in Breast Cancer Read More WILMINGTON, DE — AstraZeneca said new Phase III cancer and rare disease data presented at the American Society of Clinical Oncology annual meeting could strengthen the company’s position in several …
AstraZeneca Highlights Late-Stage Cancer, Rare Disease Data at ASCO Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) is expanding its partnership with biotechnology software firm Genesis Molecular AI in a deal worth $120 million upfront, giving the company broader access to …
Incyte Deepens AI Drug Discovery Bet in $120 Million Deal Read More
WILMINGTON, DE — The LYCRA Company emerged from Chapter 11 bankruptcy protection on May 20 after eliminating more than $1.2 billion in long-term debt and securing over $75 million in …
LYCRA Cuts Debt by $1.2 Billion, Exits Bankruptcy Protection Read More
WILMINGTON, DE — Financial services firms are facing mounting challenges managing executive compensation programs as participation expands, regulatory scrutiny increases and legacy technology systems struggle to handle growing administrative demands, …
Financial Firms Struggle to Manage Expanding Pay Programs Read More